Valuation: GlaxoSmithKline plc

Market Cap 77.4B 104B 90.3B 84.31B 146B 9,904B 148B 994B 389B 4,939B 390B 382B 16,290B P/E 2026 *
12.9x
P/E 2027 * 11.6x
Enterprise Value 95.16B 128B 111B 104B 179B 12,177B 183B 1,222B 479B 6,072B 480B 469B 20,029B EV / Sales 2026 *
2.8x
EV / Sales 2027 * 2.58x
Free-Float
92.75%
Yield 2026 *
3.6%
Yield 2027 * 3.79%
Manager TitleAgeSince
Chief Executive Officer - 01/01/2026
Director of Finance/CFO 64 01/05/2023
Chief Tech/Sci/R&D Officer - 01/12/2021
Director TitleAgeSince
Director/Board Member - 06/05/2026
Director/Board Member 64 01/01/2018
Chairman 68 01/09/2019
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-0.40% - - 104B
-2.88%-6.82%+45.11%+148.43% 1,024B
-1.20%-4.99%+47.73%+48.08% 618B
-1.84%-4.33%+24.65%+64.91% 443B
+0.68%-1.14%+39.61%+33.36% 349B
-1.66%-3.13%+31.63%+39.79% 297B
-8.96%-10.77%+3.27%+5.50% 264B
-1.37%-7.41%-3.42%-43.67% 209B
-1.69%+0.81%+25.62%+64.41% 208B
-0.53%-0.48%+13.44%+71.98% 162B
Average -1.88%-1.35%+25.29%+48.09% 397.08B
Weighted average by Cap. -2.03%-2.17%+32.88%+70.34%

Financials

2026 *2027 *
Net sales 33.97B 45.61B 39.64B 37.01B 64.06B 4,347B 65.18B 436B 171B 2,168B 171B 168B 7,151B 35.61B 47.8B 41.54B 38.79B 67.14B 4,556B 68.31B 457B 179B 2,272B 180B 176B 7,494B
Net income 5.91B 7.94B 6.9B 6.44B 11.15B 757B 11.35B 75.97B 29.76B 377B 29.83B 29.17B 1,245B 6.64B 8.91B 7.74B 7.23B 12.51B 849B 12.73B 85.23B 33.38B 423B 33.46B 32.72B 1,397B
Net Debt 17.76B 23.85B 20.73B 19.35B 33.5B 2,273B 34.08B 228B 89.37B 1,134B 89.58B 87.6B 3,739B 14.52B 19.49B 16.94B 15.82B 27.38B 1,858B 27.86B 187B 73.04B 927B 73.22B 71.6B 3,056B
Logo GlaxoSmithKline plc
GSK plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows: - pharmaceutical products (41.3%): intended mainly for HIV infection (57% of net sales), immune system disorders and respiratory diseases (28.3%), and cancer (14.7%); - OTC and parapharmaceutical medicine (30.7%); - vaccines (28%). Net sales are distributed geographically as follows: the United Kingdom (2.1%), Europe (21%), the United States (51.6%), and other (25.3%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
19.32GBP
Average target price
21.51GBP
Spread / Average Target
+11.38%

Quarterly revenue - Rate of surprise